Bo Rueda Ph.D. recently had a manuscript and review accepted, "Inaugurating High-Throughput Profiling of Extracellular
Vesicles for Earlier Ovarian Cancer Detection".
In July he presented a lecture at the 56th Annual Meeting of the Society for the Study of Reproduction in Ottawa Canada. The presentation was entitled “Defining the functional contributions of Galectin 3 in Driving the aggressive pathology of Uterine Serous Cancer”. This is a project funded by Nile Albright Research Foundation and research conducted in the Vincent Center for Reproductive Biology at Mass General Hospital.